tirzepatide approved F.D.A. Approves New Obesity Drug That Will Compete With Wegovy New Blockbuster Type 2 Medication
Description
The Content contained on this Site is provided by MTA or under license by third parties as a service to the users of this Site
People with type 2 diabetes can now take Tirzepatide to help manage their blood sugar levels, by the Food and Drug Administration (FDA)
In people without diabetes, Mounjaro still slows digestion and reduces appetite, so digestive side effects remain the most common
The GIP receptor activation adds an entirely separate pathway for metabolic improvement
Easy injection & fast results
The 2.5mg dose is not therapeutic for weight loss
